The importance of IRE1 signaling has been shown in a wide variety of diseases such as cancer, diabetes, and Alzheimer’s disease, and IRE1 modulation has emerged as a novel route for disease intervention9,10. This evidence concerns the gene ERN1 and early-onset autosomal dominant Alzheimer disease.